Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
Kontopodis E, Hatzidaki D, Varthalitis I, Kentepozidis N, Giassas S, Pantazopoulos N, Vardakis N, Rovithi M, Georgoulias V, Agelaki S. Kontopodis E, et al. J Chemother. 2013 Feb;25(1):49-55. doi: 10.1179/1973947812Y.0000000050. J Chemother. 2013. PMID: 23433445 Clinical Trial.
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.
Mountzios G, Emmanouilidis C, Vardakis N, Kontopodis E, Hatzidaki D, Popis E, Karachaliou N, Kotsakis A, Agelidou M, Georgoulias V. Mountzios G, et al. Among authors: kontopodis e. Lung Cancer. 2012 Jul;77(1):146-50. doi: 10.1016/j.lungcan.2012.02.002. Epub 2012 Mar 13. Lung Cancer. 2012. PMID: 22418242 Clinical Trial.
Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group.
Kentepozidis N, Economopoulou P, Liontos M, Kotsakis A, Boukovinas I, Vardakis N, Kontopodis E, Prinarakis E, Skaltsi T, Souglakos J, Georgoulias V. Kentepozidis N, et al. Among authors: kontopodis e. Ann Gastroenterol. 2018 Nov-Dec;31(6):698-704. doi: 10.20524/aog.2018.0311. Epub 2018 Sep 14. Ann Gastroenterol. 2018. PMID: 30386120 Free PMC article.
Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study.
Syrios J, Kouroussis C, Kotsakis A, Kentepozidis N, Kontopodis E, Kalbakis K, Vardakis N, Hatzidaki D, Polyzos A, Georgoulias V; GU Working Group of the Hellenic Oncology Research Group (HORG). Syrios J, et al. Among authors: kontopodis e. Minerva Ginecol. 2019 Jun;71(3):182-190. doi: 10.23736/S0026-4784.19.04249-7. Epub 2019 Feb 6. Minerva Ginecol. 2019. PMID: 30727721 Clinical Trial.
Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.
Papaxoinis G, Athanasiadis A, Sgouros J, Visvikis A, Drizou M, Kontopodis E, Koumarianou A, Stojanovska S, Aravantinos G, Korantzis I, Ioannou A, Varthalitis I, Doufexis D, Nikolaou M, Lypas G, Bompolaki I, Christopoulou A, Liontos M, Tsoukalas N, Mauri D, Xenidis N, Katsaounis P, Oikonomopoulos G, Boukovinas I. Papaxoinis G, et al. Among authors: kontopodis e. J Oncol. 2020 Sep 19;2020:5304516. doi: 10.1155/2020/5304516. eCollection 2020. J Oncol. 2020. PMID: 33014051 Free PMC article.
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy.
Kallergi G, Kontopodis E, Ntzifa A, Jordana-Ariza N, Karachaliou N, Pantazaka E, Charalambous HA, Psyrri A, Tsaroucha E, Boukovinas I, Koumarianou A, Hatzidaki D, Lianidou E, Georgoulias V, Rosell R, Kotsakis A. Kallergi G, et al. Among authors: kontopodis e. Cancers (Basel). 2022 Mar 19;14(6):1574. doi: 10.3390/cancers14061574. Cancers (Basel). 2022. PMID: 35326725 Free PMC article.
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period.
Matikas A, Kotsakis A, Perraki M, Hatzidaki D, Kalbakis K, Kontopodis E, Nikolaou M, Georgoulias V. Matikas A, et al. Among authors: kontopodis e. Breast Care (Basel). 2022 Jun;17(3):264-271. doi: 10.1159/000519729. Epub 2021 Oct 29. Breast Care (Basel). 2022. PMID: 35949417 Free PMC article.
Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study.
Koinis F, Zafeiriou Z, Messaritakis I, Katsaounis P, Koumarianou A, Kontopodis E, Chantzara E, Aidarinis C, Lazarou A, Christodoulopoulos G, Emmanouilides C, Hatzidaki D, Kallergi G, Georgoulias V, Kotsakis A. Koinis F, et al. Among authors: kontopodis e. Cancers (Basel). 2023 Sep 11;15(18):4511. doi: 10.3390/cancers15184511. Cancers (Basel). 2023. PMID: 37760481 Free PMC article.
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients.
Roumeliotou A, Strati A, Chamchougia F, Xagara A, Tserpeli V, Smilkou S, Lagopodi E, Christopoulou A, Kontopodis E, Drositis I, Androulakis N, Georgoulias V, Koinis F, Kotsakis A, Lianidou E, Kallergi G. Roumeliotou A, et al. Among authors: kontopodis e. Cells. 2024 May 3;13(9):782. doi: 10.3390/cells13090782. Cells. 2024. PMID: 38727318 Free PMC article.
60 results